当前位置:首页 - 行情中心 - 安旭生物(688075) - 财务分析 - 现金流量表

安旭生物

(688075)

  

流通市值:47.55亿  总市值:47.55亿
流通股本:1.27亿   总股本:1.27亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金87,427,387.52429,021,922.21339,734,120.67255,767,375.25
  收到的税费返还6,840,874.833,281,601.2532,717,313.7619,923,566.08
  收到其他与经营活动有关的现金12,830,319.9222,072,346.7644,642,619.2919,199,858.28
  经营活动现金流入小计107,098,582.24484,375,870.22417,094,053.72294,890,799.61
  购买商品、接受劳务支付的现金61,366,917.02228,414,808.18201,488,386.32156,274,963.43
  支付给职工以及为职工支付的现金40,178,299.9114,677,662.61112,547,131.1578,669,055.4
  支付的各项税费6,901,370.9549,642,119.6353,857,043.9727,374,879.96
  支付其他与经营活动有关的现金1,726,670.08101,048,445.3548,019,054.2629,053,349.29
  经营活动现金流出的平衡项目0.01000
  经营活动现金流出小计110,173,257.96493,783,035.77415,911,615.7291,372,248.08
  经营活动产生的现金流量净额-3,074,675.72-9,407,165.551,182,438.023,518,551.53
二、投资活动产生的现金流量:
  收回投资收到的现金2,935,441,427.8910,558,878,9068,804,098,122.995,718,959,380.45
  取得投资收益收到的现金109,593,880.14131,793,900.721,670,686.0321,585,014.8
  处置固定资产、无形资产和其他长期资产收回的现金净额-334,315.58--
  投资活动现金流入小计3,045,035,308.0310,691,007,122.288,825,768,809.025,740,544,395.25
  购建固定资产、无形资产和其他长期资产支付的现金10,784,74995,590,515.6454,144,956.1136,787,633
  投资支付的现金2,968,150,279.4510,319,622,6568,942,858,961.915,947,194,765.33
  支付其他与投资活动有关的现金-157,902,420.28362,910-
  投资活动现金流出小计2,978,935,028.4510,573,115,591.928,997,366,828.025,983,982,398.33
  投资活动产生的现金流量净额66,100,279.58117,891,530.36-171,598,019-243,438,003.08
三、筹资活动产生的现金流量:
  偿还债务支付的现金-280,000--
  分配股利、利润或偿付利息支付的现金-101,667,248.27106,474,954.59-
  支付其他与筹资活动有关的现金-4,062,975.58--
  筹资活动现金流出平衡项目-00-
  筹资活动现金流出小计-106,010,223.85106,474,954.59-
  筹资活动产生的现金流量净额平衡项目-00-
  筹资活动产生的现金流量净额--106,010,223.85-106,474,954.59-
四、汇率变动对现金及现金等价物的影响-1,729,883.08-40,655,864.92349,671.9684,577.43
五、现金及现金等价物净增加额61,295,720.78-38,181,723.96-276,540,863.67-239,234,874.12
  加:期初现金及现金等价物余额420,101,954.19458,283,678.15458,283,678.15458,283,678.15
  期末现金及现金等价物余额481,397,674.97420,101,954.19181,742,814.48219,048,804.03
补充资料:
  净利润-69,209,771.31-59,184,712.24
  资产减值准备-8,121,508.05--
  固定资产和投资性房地产折旧-41,906,321.98-23,156,710.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-41,906,321.98-23,156,710.62
  无形资产摊销-3,371,587.47-2,271,400.74
  长期待摊费用摊销-6,091,274.89-3,081,562.54
  处置固定资产、无形资产和其他长期资产的损失--66,315.36--131,398.95
  固定资产报废损失-1,215,672.97--
  公允价值变动损失--26,572,894.84--22,444,815.69
  财务费用-34,183,512.26-9,857,347.94
  投资损失--128,208,684.84--59,702,962.11
  递延所得税-3,098,545.79-691,825.62
  其中:递延所得税资产减少-4,710,071.86--1,645,731.09
    递延所得税负债增加--1,611,526.07-2,337,556.71
  存货的减少-5,407,047.94-11,535,381.68
  经营性应收项目的减少-20,125,685.12-9,151,444.76
  经营性应付项目的增加--54,710,167.95--33,396,636.02
  现金的期末余额-420,101,954.19-219,048,804.03
  减:现金的期初余额-458,283,678.15-458,283,678.15
  现金及现金等价物的净增加额--38,181,723.96--239,234,874.12
公告日期2026-04-302026-04-302025-10-312025-08-20
审计意见(境内)标准无保留意见
TOP↑